Modern medical studies show that chemotherapy can help most cancer patients, especially
for those diagnosed early, to stabilize their disease conditions from months to years, which …

Oncolytic virotherapy is a viable chemotherapeutic agent that identifies and kills tumor cells
using replication-competent pathogens. Oncolytic alphavirus M1 is a naturally existing …

In recent times the possibilities of treating cancer using specific types of viruses are being
explored. Here we consider a nonlinear mathematical model based on ordinary differential …

We formulate a mathematical model of functional partial differential equations for oncolytic
virotherapy which incorporates virus diffusivity, tumor cell diffusion, and the viral lytic cycle …

In part II, we analyze our stochastic model which incorporates microenvironmental noises
and uncertainties related to immune responses. Outcomes of the therapy in our model are …

Celyvir is an advanced therapy medicine, consisting of mesenchymal stem cells (MSCs)
containing the oncolytic virus ICOVIR 5. This paper sets out a dynamic system which …

Oncolytic virotherapy is known as a new treatment to employ less virulent viruses to
specifically target and damage cancer cells. This work presents a cellular automata model of …

Oncolytic viruses (OV) represent an encouraging new therapeutic concept for treatment of
human cancers. OVs specifically replicate in tumor cells and initiate cell lysis whilst tumor …

Combined oncolytic virotherapy and immunotherapy are novel treatment protocols that
represent a promising and advantageous strategy for various cancers, surpassing …

The viral lytic cycle is an important process in oncolytic virotherapy. Most mathematical
models for oncolytic virotherapy do not incorporate this process. In this article, we propose a …